AOD9604 5MG — Targeted Lipolysis & Metabolic Support

Optimize your metabolic efficiency with AOD9604, a precision-engineered peptide designed for targeted fat reduction. Unlike traditional growth hormone treatments that may increase hunger or impact blood sugar, AOD9604 focuses specifically on fat oxidation, making it an ideal choice for those seeking weight management without the metabolic side effects of full-length HGH.

Specifications

Product Overview & Mechanism of Action

AOD9604, also known as Tyr-hGH Frag 176-191, is a specialized peptide derived from the specific 176-191 amino acid sequence of the Human Growth Hormone (HGH) polypeptide. It has been engineered to provide the fat-burning benefits of HGH without the systemic side effects typically associated with increased growth hormone levels.

The mechanism of action for AOD9s604 focuses on stimulating lipolysis—the breakdown of fats—and inhibiting lipogenesis, which is the process of converting non-fatty foods into body fat. This peptide is uniquely capable of triggering fat release from obese fat cells, particularly in the abdominal region, by activating fat oxidation through a pathway independent of the standard HGH receptor.

Key Benefits:

• Targeted Fat Reduction: Promotes the release of fat from adipose tissue, specifically targeting abdominal stores.
• Metabolic Support: Stimulates lipolysis and inhibits the accumulation of new fat cells.
• No Appetite Stimulation: Unlike other weight loss protocols, AOD9604 does not increase hunger or cortisol levels.
• No Blood Sugar Impact: Maintains carbohydrate metabolism integrity, making it safer for those concerned with insulin sensitivity.
• Regenerative Potential: Research suggests potential benefits for cartilage repair and regeneration, especially when used in conjunction with BPC 157.

Research & Safety Profile

AOD9604 (Advanced Obesity Drug) was originally developed by Professor Frank Ng at Monash University. It was designed to isolate the fat-burning properties of HGH while removing the muscle-building and appetite-inducing components. This makes it a highly efficient tool for fat oxidation without the risk of excessive tissue growth.

Clinical studies have demonstrated that AOD9604 possesses a highly favorable safety and tolerability profile. In laboratory tests, it has shown no negative impact on carbohydrate metabolism and has been noted for its safety in human studies, recently obtaining Human GRAS (Generally Recognized as Safe) status in the USA. It offers a professional-grade solution for those seeking the metabolic benefits of HGH-related sequences without the adverse effects of full-length hormone treatments.